The role of platelet-activating factor in conscious, normotensive endotoxemia

Journal of Surgical Research

Volumn 68, Issue 2, 1997, Pages 170-174

  Ephgrave, Kimberly ^a   Kremer, Ted ^a   Broadhurst, Kimberly ^a   Cullen, Joseph ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; ENDOTOXEMIA; HEMODYNAMIC MONITORING; HYPOTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH SECRETION;

EID: 0031105473     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5009     Document Type: Article

References (23)

1. 1. Braquet, P., Touqui, T., Shen, Y., and Vargaftig, B. B. Perspectives in platelet-activating factor research. Pharmacol. Rev. 39(2): 97, 1987.
2. 2. Rosam, A., Wallace, J. L., and Whittle, B. Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature 319: 4, 1986.
3. 3. Wallace, J. L., and Whittle, B. J. Prevention of endotoxin-induced gastrointestinal damage by CV-3988, an antagonist of platelet-activating factor. Eur. J. Pharmacol. 124: 209, 1986.
4. 4. Esplugues, J. V., and Whittle, B. J. Mechanisms contributing to gastric motility changes induced by PAF-acether and endotoxin in rats. Am. J. Physiol. 256: G275, 1989.
5. 5. Pons, L., Droy-Lefaix, T., Braquet, P., and Bueno, L. Role of free radicals and platelet-activating factor in the genesis of intestinal motor disturbances. Gastroenterology 100: 946, 1991.
6. 6. Martinez-Cuesta, M., Barrachina, M. D., Pique, J. M., et al. The role of nitric oxide and platelet-activating factor in the inhibition by endotoxin of pentagastrin-stimulated gastric acid secretion. Eur. J. Pharmacol. 218: 351, 1992.
7. 7. Caplan, M. S., Kelly, A., and Hsueh, W. Endotoxin and hypoxia-induced intestinal necrosis in rats: The role of platelet activating factor. Pediatr. Res. 31(5): 428, 1992.
8. 8. Sun, X., Caplan, M., Liu, Y., and Hsueh, W. Endotoxin-resistant mice are protected from PAF-induced bowel injury and death: Role of TNF, complement activation, and endogenous PAF production. Dig. Dis. Sci. 40(3): 495, 1995.
9. 9. Terashita, Z., Imura, U., and Nishikawa, K. Is platelet activating factor (PAF) a mediator of endotoxin shock? Eur. J. Pharmacol. 109: 257, 1985.
10. 10. Terashita, Z., Tsushima, S., Yoshioka, Y., Nomura, H., Inada, Y., and Nishikawa, K. CV-3988-A specific antagonist of platelet activating factor (PAF). Life Sci. 32: 1975, 1983.
11. 11. McManus, L. M., Hanahan, D. J., Demopoulos, C. A., and Pinckard, R. N. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC) infusion in the rabbit. Immunopharmacology 5: 197, 1983.
12. 12. Bessin, P., Bonnet, J., Apffel, P., Soulard, C., Desgrou, L., Pelassi, I., and Benveniste, J. Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. Eur. J. Pharmcol. 86: 403, 1983.
13. 13. Chang, S. W., Feddersen, C. O., Herndon, P. M., and Voelkel, N. F. Platelet activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J. Clin. Invest. 79: 1498, 1987.
14. 14. Bussolino, F., Porcellini, M. G., Varese, L., and Bosia, A. Intravascular release of platelet-activating factor in children with sepsis. Thromb. Res. 48: 619, 1987.
15. 15. Hoehner, J., Ephgrave, K., and Broadhurst, K. Endotoxemia and gastric physiology. Circ. Shock 37: 37, 1992.
16. 16. Wallace, J., and Whittle, B. Effects of inhibitors of arachidonic acid metabolism on PAF-induced gastric mucosal necrosis and haemonconcentration. Br. J. Pharmacol. 89: 415, 1986.
17. 17. Pique, J., Ayuso, P., Bilbao, J., and Teres, J. Effects of stimulation and inhibition of acid secretion on gastric damage induced by platelet-activating factor. Dig. Dis. Sci. 36(12): 1715, 1991.
18. 18. Ephgrave, K., Kleiman-Wexler, R., Jurich, T., Hahn, S., Schulze, K., and Shirazi, S. The role of gastric motility in mucosal injury. Clin. Res. 39: 775A, 1991.
19. 19. Yan, Z. Y., Wood, J. G., and Cheung, L. Y. Platelet activating factor-induced changes in gastric motility and vascular resistance. Am. J. Surg. 163: 23, 1996.
20. 20. Garrick, T., Buack, S., and Bass, P. Gastric motility is a major factor in cold restraint-induced lesion formation in rats. Am. J. Physiol. 250: G191, 1986.
21. 21. Wirthlin, D. J., Cullen, J. J., Spates, S. T., Conklin, J. L., Murray, J., Caropreso, D. K., and Ephgrave, K. S. Gastrointestinal transit during endotoxemia: The role of nitric oxide. J. Surg. Res. 60: 307, 1996.
22. 22. Dhainaut, J. F. A., Tenaillon, A., Tulzo, Y. L., Schlemmer, B., Solet, J. P., Wolf, M., Holzapfel, L., Zeni, F., Dreyfuss, D., Mira, J. P., Vathaire, F., and Guinot, P. Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A radomized, double-blind, placebo-controlled, multicenter clinical trial. Crit. Care Med. 22: 1720, 1994.
23. 23. Albert, D. H., Luo, G., Magoc, T. J., Tapang, P., Homs, J. H., Davidson, S. K., Summers, J. B., and Carter, G. W. ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious rats. Shock 6(2): 112, 1996.